Spiroxasone
A synthetic steroidal antimineralocorticoid and antiandrogen
Spiroxasone | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Spiroxasone is a synthetic steroidal antimineralocorticoid and antiandrogen that was developed for the treatment of conditions such as hypertension and heart failure. It is a derivative of spironolactone, a well-known potassium-sparing diuretic.
Pharmacology
Mechanism of Action
Spiroxasone acts as an antagonist of the mineralocorticoid receptor, which is responsible for the effects of aldosterone in the body. By blocking this receptor, spiroxasone reduces sodium reabsorption and increases potassium retention, leading to a diuretic effect. Additionally, it has antiandrogenic properties, which means it can block the effects of androgens like testosterone.
Pharmacokinetics
The pharmacokinetic profile of spiroxasone includes its absorption, distribution, metabolism, and excretion. Like other steroidal antimineralocorticoids, it is metabolized in the liver and excreted primarily in the urine.
Clinical Use
Spiroxasone was investigated for use in conditions such as hypertension, heart failure, and hirsutism. However, it was never marketed, and its clinical use remains limited to research settings.
Side Effects
Potential side effects of spiroxasone include hyperkalemia, gynecomastia, and menstrual irregularities. These are similar to those observed with other antimineralocorticoids and antiandrogens.
Chemical Structure
Spiroxasone is a synthetic steroid with a chemical structure similar to that of spironolactone. It contains a lactone ring and a thioacetate group, which are characteristic of this class of compounds.
Related Compounds
Spiroxasone is related to other antimineralocorticoids such as spironolactone and eplerenone. These compounds share similar mechanisms of action and therapeutic uses.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD